Refining HIV Risk: The Modifying Effects of Youth, Gender and Education among People Who Inject Drugs in Poland

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Czerwinski, Michal ^a   McNutt, Louise Anne ^b   DeHovitz, Jack A ^c   Zielinski, Andrzej ^a   Rosinska, Magdalena ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b UNIVERSITY AT ALBANY   (United States)

^c Downstate Health Sciences University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RATE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; POLAND; RISK ASSESSMENT; SEX DIFFERENCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; CONFIDENCE INTERVALS; DEMOGRAPHY; EDUCATION; FEMALE; HIV INFECTIONS; HUMANS; INJECTIONS; MALE; POLAND; PREVALENCE; RISK FACTORS; RISK-TAKING; SEX CHARACTERISTICS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84880714177     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068018     Document Type: Article

References (36)

1. revision of the European AIDS surveillance case definition (1993) European Centre for the Epidemiological Monitoring of AIDS, Quarterly Report 37: 23-28.
2. European case definition for AIDS surveillance in children- revision 1995 (1995) European Centre for the Epidemiological Monitoring of AIDS, Quarterly Report 48: 46-53.
3. Stark K, Wirth D, Sieroslawski J, Godwod-Sikorska C, Mueller R, (1994) High HIV seroprevalence in injecting drug users in Warsaw, Poland. J Acquir Immune Defic Syndr 7: 877-878.
4. Niedzwiedzka-Stadnik M, Rosinska M, (2012) HIV and AIDS in Poland in 2010. Przegl Epidemiol 66: 315-323.
5. HIV/AIDS Surveillance in Europe (2007) European Centre for the Epidemiological Monitoring of AIDS, End-year report 75.
6. Malczewski A, Bukowska B, Jablonski P, Kidawa M, Struzik M, et al. (2009) Annual report 2009 Poland: Drug situation. National Bureau for Drug Prevention, Warsaw, Poland.
7. Rosinska M (2006) Current trends in HIV/AIDS epidemiology in Poland, 1999-2004. Euro Surveill. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=618. Accessed 24 June 2013.
8. Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, et al. (2002) Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 166: 894-899.
9. Nelson KE, Vlahov D, Solomon L, Cohn S, Muñoz A, (1995) Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore. Arch Intern Med 155: 1305-1311.
10. Bennett GA, Velleman RD, Barter G, Bradbury C, (2000) Gender differences in sharing injecting equipment by drug users in England. AIDS Care 12: 77-87.
11. Davies AG, Dominy NJ, Peters AD, Richardson AM, (1996) Gender differences in HIV risk behaviour of injecting drug users in Edinburgh. AIDS Care 8: 517-527.
12. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, et al. (2003) Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health 80: 137-46.
13. Cleland CM, Des Jarlais DC, Perlis TE, Stimson G, Poznyak V, (2007) WHO Phase II Drug Injection Collaborative Study Group. HIV risk behaviors among female IDUs in developing and transitional countries. BMC Public Health Available: http://www.biomedcentral.com/1471-2458/7/271. Accessed 24 June 2013.
14. Frajzyngier V, Neaigus A, Gyarmathy VA, Miller M, Friedman SR, (2007) Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend 89: 145-152.
15. Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D, Johnson L, et al. (2001) Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med 161: 1281-1288.
16. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, et al. (2001) Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357: 1397-1401.
17. Lau JT, Tsui HY, Zhang Y, Cheng F, Zhang L, et al. (2008) Comparing HIV-related syringe-sharing behaviors among female IDU engaging versus not engaging in commercial sex. Drug Alcohol Depend 97: 54-63.
18. Platt L, Rhodes T, Lowndes CM, Madden P, Sarang A, et al. (2005) Impact of gender and sex work on sexual and injecting risk behaviors and their association with HIV positivity among injecting drug users in an HIV epidemic in Togliatti City, Russian Federation. Sex Transm Dis 32: 605-612.
19. Revision of HIV testing strategies for surveillance (2006) Wkly Epidemiol Rec 81: 461-464.
20. McNutt LA, Wu C, Xue X, Hafner JP, (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157: 940-3.
21. Deddens JA, Petersen MR, Lei X (2003) Estimation of prevalence ratios when PROC GENMOD does not converge, SUGI Proceedings. Available: http://www2.sas.com/proceedings/sugi28/270-28.pdf. Accessed 24 June 2013.
22. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K, (2010) Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction 105: 1254-1264.
23. Lum PJ, Sears C, Guydish J, (2005) Injection risk behavior among women syringe exchangers in San Francisco. Subst Use Misuse 40: 1681-1696.
24. Becker Buxton M, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, et al. (2004) Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend 75: 177-183.
25. Vidal-Trécan G, Coste J, Coeuret M, Delamare N, Varescon-Pousson I, et al. (1998) Risk behaviors of intravenous drug users: are females taking more risks of HIV and HCV transmission? Rev Epidemiol Sante Publique 46: 193-204.
26. Estebanez PE, Russell NK, Aguilar MD, Béland F, Zunzunegui MV, (2000) Women, drugs and HIV/AIDS: results of a multicentre European study. Int J Epidemiol 29: 734-743.
27. Hasnain M, Levy JA, Mensah EK, Sinacore JM, (2007) Association of educational attainment with HIV risk in African American active injection drug users. AIDS Care 19: 87-91.
28. Strathdee SA, Lozada R, Ojeda VD, Pollini RA, Brouwer KC, et al. (2008) Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002690. Accessed 24 June 2013.
29. Roberts A, Mathers B, and Degenhardt L, et al. (2010) Women who inject drugs: A review of their risks, experiences and needs, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, Australia.
30. Malczewski A, Struzik M, Jaskiewicz A (2008) First national survey low-thresholds clients and services in 2008. National Bureau for Drug Prevention, Warsaw, Poland.
31. Malczewski A, Bukowska B, Jablonski P, Struzik M, Kidawa M, et al. (2010) Poland: New Development, Trends and in-depth information on selected issues. National Bureau for Drug Prevention, Warsaw, Poland.
32. Svensson NP, Horner-Knight S, Husebye T, Muerwald S, Schaffranek J, (2003) Outreach work with young people: Young drug users and young people at risk. Council of Europe Available: https://wcd.coe.int/ViewDoc.jsp?id=1302697&Site=COE. Accessed 24 June 2013.
33. Pinkham S, Stoicescu C, Myers B, (2012) Developing effective health interventions for women who inject drugs: key areas and recommendations for program development and policy. Adv Prev Med Available: http://www.hindawi.com/journals/apm/2012/269123/. Accessed 24 June 2013.
34. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, et al. (2010) Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 376: 285-301.
35. Umesh Sharma H (2012) Outreach for injecting drug users. Standard operating procedure. United Nations Office on Drugs and Crime, Regional Office for South Asia.
36. Gollub EL, Rey D, Obadia Y, Moatti JP, (1998) Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sex Transm Dis 25: 483-488.